Merit Medical Systems Debt to Equity Ratio 2010-2024 | MMSI
Current and historical debt to equity ratio values for Merit Medical Systems (MMSI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Merit Medical Systems debt/equity for the three months ending September 30, 2024 was 0.57.
Merit Medical Systems Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-09-30 |
$1.06B |
$1.32B |
0.80 |
2024-06-30 |
$1.09B |
$1.28B |
0.85 |
2024-03-31 |
$1.09B |
$1.24B |
0.88 |
2023-12-31 |
$1.12B |
$1.20B |
0.93 |
2023-09-30 |
$0.58B |
$1.23B |
0.47 |
2023-06-30 |
$0.63B |
$1.20B |
0.53 |
2023-03-31 |
$0.51B |
$1.17B |
0.44 |
2022-12-31 |
$0.52B |
$1.14B |
0.45 |
2022-09-30 |
$0.54B |
$1.09B |
0.50 |
2022-06-30 |
$0.56B |
$1.07B |
0.52 |
2022-03-31 |
$0.57B |
$1.06B |
0.54 |
2021-12-31 |
$0.61B |
$1.04B |
0.59 |
2021-09-30 |
$0.63B |
$1.01B |
0.62 |
2021-06-30 |
$0.65B |
$0.99B |
0.66 |
2021-03-31 |
$0.68B |
$0.98B |
0.69 |
2020-12-31 |
$0.71B |
$0.96B |
0.74 |
2020-09-30 |
$0.74B |
$0.93B |
0.79 |
2020-06-30 |
$0.79B |
$0.93B |
0.85 |
2020-03-31 |
$0.81B |
$0.94B |
0.86 |
2019-12-31 |
$0.81B |
$0.95B |
0.85 |
2019-09-30 |
$0.81B |
$0.95B |
0.86 |
2019-06-30 |
$0.79B |
$0.95B |
0.83 |
2019-03-31 |
$0.75B |
$0.94B |
0.80 |
2018-12-31 |
$0.69B |
$0.93B |
0.74 |
2018-09-30 |
$0.39B |
$0.92B |
0.42 |
2018-06-30 |
$0.59B |
$0.70B |
0.85 |
2018-03-31 |
$0.55B |
$0.69B |
0.80 |
2017-12-31 |
$0.44B |
$0.68B |
0.64 |
2017-09-30 |
$0.42B |
$0.67B |
0.63 |
2017-06-30 |
$0.39B |
$0.67B |
0.58 |
2017-03-31 |
$0.36B |
$0.65B |
0.56 |
2016-12-31 |
$0.45B |
$0.50B |
0.89 |
2016-09-30 |
$0.44B |
$0.49B |
0.91 |
2016-06-30 |
$0.34B |
$0.48B |
0.70 |
2016-03-31 |
$0.33B |
$0.47B |
0.70 |
2015-12-31 |
$0.31B |
$0.47B |
0.67 |
2015-09-30 |
$0.31B |
$0.46B |
0.68 |
2015-06-30 |
$0.30B |
$0.45B |
0.67 |
2015-03-31 |
$0.30B |
$0.44B |
0.67 |
2014-12-31 |
$0.31B |
$0.44B |
0.72 |
2014-09-30 |
$0.32B |
$0.42B |
0.76 |
2014-06-30 |
$0.33B |
$0.42B |
0.79 |
2014-03-31 |
$0.33B |
$0.41B |
0.81 |
2013-12-31 |
$0.32B |
$0.41B |
0.80 |
2013-09-30 |
$0.32B |
$0.40B |
0.82 |
2013-06-30 |
$0.34B |
$0.39B |
0.87 |
2013-03-31 |
$0.33B |
$0.38B |
0.86 |
2012-12-31 |
$0.32B |
$0.38B |
0.85 |
2012-09-30 |
$0.14B |
$0.38B |
0.36 |
2012-06-30 |
$0.13B |
$0.37B |
0.35 |
2012-03-31 |
$0.13B |
$0.36B |
0.35 |
2011-12-31 |
$0.09B |
$0.36B |
0.25 |
2011-09-30 |
$0.07B |
$0.35B |
0.19 |
2011-06-30 |
$0.11B |
$0.35B |
0.32 |
2011-03-31 |
$0.13B |
$0.25B |
0.54 |
2010-12-31 |
$0.13B |
$0.24B |
0.57 |
2010-09-30 |
$0.13B |
$0.23B |
0.58 |
2010-06-30 |
$0.05B |
$0.23B |
0.22 |
2010-03-31 |
$0.05B |
$0.22B |
0.24 |
2009-12-31 |
$0.05B |
$0.22B |
0.24 |
2009-09-30 |
$0.05B |
$0.21B |
0.25 |
2009-06-30 |
$0.05B |
$0.20B |
0.26 |
2009-03-31 |
$0.04B |
$0.20B |
0.22 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$6.102B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|